| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transition metal ion binding | LARGE2 ESRRB GATA1 NSD1 LANCL1 APOBEC3A SETDB1 MELTF P3H2 HLTF ZNF638 TNKS PLOD2 D2HGDH ALOX5 ALOX12B ZMYM3 PRNP DNMT1 | 5.15e-06 | 1189 | 99 | 19 | GO:0046914 |
| GeneOntologyMolecularFunction | p53 binding | 4.03e-05 | 77 | 99 | 5 | GO:0002039 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 5.78e-05 | 83 | 99 | 5 | GO:1990841 | |
| GeneOntologyMolecularFunction | transcription factor binding | MED6 HIF1A ERCC1 ESRRB GATA1 NSD1 GSK3B DDX5 MAPK3 UHRF2 RBFOX2 HDAC1 DNMT1 | 8.75e-05 | 753 | 99 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.28e-04 | 98 | 99 | 5 | GO:0051213 | |
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 1.45e-04 | 4 | 99 | 2 | GO:0004052 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | HIF1A ESRRB GATA1 NSD1 GSK3B DDX5 MAPK3 UHRF2 RBFOX2 HDAC1 DNMT1 | 1.45e-04 | 582 | 99 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.29e-04 | 417 | 99 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 2.51e-04 | 25 | 99 | 3 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 2.83e-04 | 26 | 99 | 3 | GO:0016701 | |
| GeneOntologyBiologicalProcess | regulation of telomere capping | 7.73e-06 | 27 | 98 | 4 | GO:1904353 | |
| GeneOntologyBiologicalProcess | telomere capping | 4.24e-05 | 41 | 98 | 4 | GO:0016233 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 6.47e-05 | 368 | 98 | 9 | GO:0030111 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere capping | 6.74e-05 | 17 | 98 | 3 | GO:1904355 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 7.26e-05 | 147 | 98 | 6 | GO:0030278 | |
| Domain | LANC-like | 8.32e-05 | 3 | 99 | 2 | IPR007822 | |
| Domain | LANC_like | 8.32e-05 | 3 | 99 | 2 | SM01260 | |
| Domain | LANC_like | 8.32e-05 | 3 | 99 | 2 | PF05147 | |
| Domain | LanC-like_prot_euk | 8.32e-05 | 3 | 99 | 2 | IPR020464 | |
| Domain | AbLIM_anchor | 1.66e-04 | 4 | 99 | 2 | PF16182 | |
| Domain | AbLIM_anchor | 1.66e-04 | 4 | 99 | 2 | IPR032402 | |
| Domain | EGF-like_dom | 3.61e-04 | 249 | 99 | 7 | IPR000742 | |
| Domain | - | 4.11e-04 | 6 | 99 | 2 | 3.90.1290.10 | |
| Domain | LipOase_mml | 4.11e-04 | 6 | 99 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 4.11e-04 | 6 | 99 | 2 | PS00711 | |
| Domain | LipOase_C | 4.11e-04 | 6 | 99 | 2 | IPR013819 | |
| Domain | GAR | 4.11e-04 | 6 | 99 | 2 | PS51460 | |
| Domain | LIPOXYGENASE_2 | 4.11e-04 | 6 | 99 | 2 | PS00081 | |
| Domain | LipOase_Fe_BS | 4.11e-04 | 6 | 99 | 2 | IPR020833 | |
| Domain | LipOase_CS | 4.11e-04 | 6 | 99 | 2 | IPR020834 | |
| Domain | GAS2 | 4.11e-04 | 6 | 99 | 2 | PF02187 | |
| Domain | Lipoxygenase | 4.11e-04 | 6 | 99 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 4.11e-04 | 6 | 99 | 2 | PS51393 | |
| Domain | LipOase | 4.11e-04 | 6 | 99 | 2 | IPR000907 | |
| Domain | - | 4.11e-04 | 6 | 99 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 4.11e-04 | 6 | 99 | 2 | IPR003108 | |
| Domain | GAS2 | 4.11e-04 | 6 | 99 | 2 | SM00243 | |
| Domain | Plectin | 5.74e-04 | 7 | 99 | 2 | PF00681 | |
| Domain | Plectin_repeat | 5.74e-04 | 7 | 99 | 2 | IPR001101 | |
| Domain | PLEC | 5.74e-04 | 7 | 99 | 2 | SM00250 | |
| Domain | PHD | 6.77e-04 | 75 | 99 | 4 | PF00628 | |
| Domain | 6hp_glycosidase | 7.63e-04 | 8 | 99 | 2 | IPR012341 | |
| Domain | HP | 7.63e-04 | 8 | 99 | 2 | PS51089 | |
| Domain | - | 7.63e-04 | 8 | 99 | 2 | 1.10.950.10 | |
| Domain | VHP | 7.63e-04 | 8 | 99 | 2 | SM00153 | |
| Domain | VHP | 7.63e-04 | 8 | 99 | 2 | PF02209 | |
| Domain | - | 7.63e-04 | 8 | 99 | 2 | 1.50.10.10 | |
| Domain | Villin_headpiece | 7.63e-04 | 8 | 99 | 2 | IPR003128 | |
| Domain | Znf_PHD-finger | 8.23e-04 | 79 | 99 | 4 | IPR019787 | |
| Domain | - | 1.15e-03 | 39 | 99 | 3 | 2.120.10.30 | |
| Domain | PHD | 1.28e-03 | 89 | 99 | 4 | SM00249 | |
| Domain | SET | 1.33e-03 | 41 | 99 | 3 | PF00856 | |
| Domain | Znf_PHD | 1.39e-03 | 91 | 99 | 4 | IPR001965 | |
| Domain | Ephrin_rec_like | 1.48e-03 | 11 | 99 | 2 | PF07699 | |
| Domain | BAH | 1.48e-03 | 11 | 99 | 2 | PS51038 | |
| Domain | BAH_dom | 1.48e-03 | 11 | 99 | 2 | IPR001025 | |
| Domain | BAH | 1.48e-03 | 11 | 99 | 2 | SM00439 | |
| Domain | BAH | 1.48e-03 | 11 | 99 | 2 | PF01426 | |
| Domain | EGF | 1.58e-03 | 235 | 99 | 6 | SM00181 | |
| Domain | EGF_3 | 1.58e-03 | 235 | 99 | 6 | PS50026 | |
| Domain | ZF_PHD_2 | 1.63e-03 | 95 | 99 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.70e-03 | 96 | 99 | 4 | PS01359 | |
| Domain | EGF_dom | 1.77e-03 | 12 | 99 | 2 | IPR024731 | |
| Domain | EGF_3 | 1.77e-03 | 12 | 99 | 2 | PF12947 | |
| Domain | SET | 1.86e-03 | 46 | 99 | 3 | SM00317 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.86e-03 | 46 | 99 | 3 | IPR011042 | |
| Domain | 6-hairpin_glycosidase-like | 2.09e-03 | 13 | 99 | 2 | IPR008928 | |
| Domain | SET_dom | 2.36e-03 | 50 | 99 | 3 | IPR001214 | |
| Domain | SET | 2.36e-03 | 50 | 99 | 3 | PS50280 | |
| Domain | EGF_1 | 2.37e-03 | 255 | 99 | 6 | PS00022 | |
| Domain | Helicase_C | 2.53e-03 | 107 | 99 | 4 | PF00271 | |
| Domain | HELICc | 2.53e-03 | 107 | 99 | 4 | SM00490 | |
| Domain | Helicase_C | 2.61e-03 | 108 | 99 | 4 | IPR001650 | |
| Domain | EGF-like_CS | 2.67e-03 | 261 | 99 | 6 | IPR013032 | |
| Domain | HELICASE_CTER | 2.70e-03 | 109 | 99 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.70e-03 | 109 | 99 | 4 | PS51192 | |
| Domain | DEXDc | 2.70e-03 | 109 | 99 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.79e-03 | 110 | 99 | 4 | IPR014001 | |
| Domain | LY | 2.79e-03 | 15 | 99 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.79e-03 | 15 | 99 | 2 | IPR000033 | |
| Domain | EGF_2 | 2.87e-03 | 265 | 99 | 6 | PS01186 | |
| Domain | Post-SET_dom | 3.18e-03 | 16 | 99 | 2 | IPR003616 | |
| Domain | DENN | 3.18e-03 | 16 | 99 | 2 | SM00799 | |
| Domain | PostSET | 3.18e-03 | 16 | 99 | 2 | SM00508 | |
| Domain | P4Hc | 3.18e-03 | 16 | 99 | 2 | SM00702 | |
| Domain | DENN | 3.18e-03 | 16 | 99 | 2 | PF02141 | |
| Domain | dDENN | 3.18e-03 | 16 | 99 | 2 | PF03455 | |
| Domain | UDENN | 3.18e-03 | 16 | 99 | 2 | PS50946 | |
| Domain | DDENN | 3.18e-03 | 16 | 99 | 2 | PS50947 | |
| Domain | dDENN | 3.18e-03 | 16 | 99 | 2 | SM00801 | |
| Domain | dDENN_dom | 3.18e-03 | 16 | 99 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.18e-03 | 16 | 99 | 2 | IPR005113 | |
| Domain | DENN | 3.18e-03 | 16 | 99 | 2 | PS50211 | |
| Domain | DENN_dom | 3.18e-03 | 16 | 99 | 2 | IPR001194 | |
| Domain | Pro_4_hyd_alph | 3.18e-03 | 16 | 99 | 2 | IPR006620 | |
| Domain | POST_SET | 3.18e-03 | 16 | 99 | 2 | PS50868 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 3.59e-03 | 17 | 99 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 3.59e-03 | 17 | 99 | 2 | PS51059 | |
| Domain | PARP | 3.59e-03 | 17 | 99 | 2 | PF00644 | |
| Domain | - | 3.59e-03 | 17 | 99 | 2 | 3.90.228.10 | |
| Domain | LH2 | 4.03e-03 | 18 | 99 | 2 | SM00308 | |
| Domain | 2OG-FeII_Oxy | 4.48e-03 | 19 | 99 | 2 | PF03171 | |
| Domain | EGF | 4.54e-03 | 126 | 99 | 4 | PF00008 | |
| Domain | PWWP | 4.97e-03 | 20 | 99 | 2 | SM00293 | |
| Domain | Zinc_finger_PHD-type_CS | 4.97e-03 | 65 | 99 | 3 | IPR019786 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 3.67e-06 | 44 | 76 | 5 | M13720 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 2.41e-05 | 11 | 76 | 3 | M42523 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 3.20e-05 | 34 | 76 | 4 | M27405 | |
| Pathway | KEGG_AXON_GUIDANCE | 6.76e-05 | 129 | 76 | 6 | M5539 | |
| Pathway | PID_PS1_PATHWAY | 1.07e-04 | 46 | 76 | 4 | M70 | |
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 2.01e-08 | 11 | 99 | 4 | 16815997 | |
| Pubmed | 1.45e-07 | 381 | 99 | 10 | 18676680 | ||
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 22411829 | ||
| Pubmed | Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. | 4.45e-07 | 6 | 99 | 3 | 19759537 | |
| Pubmed | RPN1 LANCL1 LANCL2 GSK3B DDX5 FASN THOP1 ATP6V0D1 DST CLPTM1 MACF1 RAB21 PLOD2 DNAJC3 HDAC1 DNMT1 | 7.83e-07 | 1297 | 99 | 16 | 33545068 | |
| Pubmed | RPN1 LANCL2 DENND4C DDX5 ABLIM1 FASN DST LRP6 GIGYF2 MACF1 ASCC3 HDAC1 | 8.49e-07 | 708 | 99 | 12 | 39231216 | |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 1.29e-06 | 374 | 99 | 9 | 19625176 | |
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 1.54e-06 | 382 | 99 | 9 | 19170196 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | LARGE2 RPN1 LANCL1 PGAP4 TGFBR1 MELTF PTPRK P3H2 CLPTM1 LRP6 RAB21 PLOD2 DNAJC3 PRNP DNMT1 | 1.55e-06 | 1201 | 99 | 15 | 35696571 |
| Pubmed | GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. | 1.86e-06 | 9 | 99 | 3 | 15469820 | |
| Pubmed | 2.05e-06 | 130 | 99 | 6 | 12421765 | ||
| Pubmed | GABRG2 RPN1 CORO1C LANCL2 GSK3B DDX5 USP31 ABLIM1 FASN ATP6V0D1 DST STXBP1 MACF1 MAPK3 ABLIM2 PRNP | 2.80e-06 | 1431 | 99 | 16 | 37142655 | |
| Pubmed | 3.20e-06 | 418 | 99 | 9 | 34709266 | ||
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 3.39e-06 | 421 | 99 | 9 | 19692168 | |
| Pubmed | RPN1 CORO1C NSD1 ABLIM1 FASN ANAPC1 GIGYF2 ASCC3 HDAC1 DNMT1 | 3.92e-06 | 549 | 99 | 10 | 38280479 | |
| Pubmed | 7.05e-06 | 347 | 99 | 8 | 17114649 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | HIF1A RPN1 LANCL1 DDX5 KIFAP3 ABLIM1 FASN PTPRK ANAPC1 CLPTM1 TNKS RAB21 ZMYM3 PRNP | 7.99e-06 | 1203 | 99 | 14 | 29180619 |
| Pubmed | Tankyrase is necessary for canonical Wnt signaling during kidney development. | 8.02e-06 | 2 | 99 | 2 | 20549720 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 28901450 | ||
| Pubmed | Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling. | 8.02e-06 | 2 | 99 | 2 | 27494558 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 20022962 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 10551817 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11002341 | ||
| Pubmed | The ABA/LANCL1/2 Hormone/Receptor System Controls Adipocyte Browning and Energy Expenditure. | 8.02e-06 | 2 | 99 | 2 | 36834900 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 37661113 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 36604718 | ||
| Pubmed | HDAC1 is required for GATA-1 transcription activity, global chromatin occupancy and hematopoiesis. | 8.02e-06 | 2 | 99 | 2 | 34450641 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 34617577 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21586567 | ||
| Pubmed | PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. | 8.02e-06 | 2 | 99 | 2 | 29603227 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22050843 | ||
| Pubmed | Regulation of tankyrase activity by a catalytic domain dimer interface. | 8.02e-06 | 2 | 99 | 2 | 30055800 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 20131247 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 31704828 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 17682057 | ||
| Pubmed | DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicular cancer. | 8.02e-06 | 2 | 99 | 2 | 16960727 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 30415773 | ||
| Pubmed | Effect of hypoxia on the expression of iron regulatory proteins 1 and the mechanisms involved. | 8.02e-06 | 2 | 99 | 2 | 21360641 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24027299 | ||
| Pubmed | Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions. | 8.02e-06 | 2 | 99 | 2 | 24291818 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 32533074 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 26151480 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 27365055 | ||
| Pubmed | Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. | 8.02e-06 | 2 | 99 | 2 | 18612384 | |
| Pubmed | Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy. | 8.02e-06 | 2 | 99 | 2 | 28723574 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 18026951 | ||
| Pubmed | Novel alterations in IFT172 and KIFAP3 may induce basal cell carcinoma. | 8.02e-06 | 2 | 99 | 2 | 34674729 | |
| Pubmed | Structural insights into SAM domain-mediated tankyrase oligomerization. | 8.02e-06 | 2 | 99 | 2 | 27328430 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 26848522 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 31339433 | ||
| Pubmed | GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line. | 8.02e-06 | 2 | 99 | 2 | 24333432 | |
| Pubmed | Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. | 8.02e-06 | 2 | 99 | 2 | 24116873 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21640852 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22036844 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15795250 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 38472175 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 20126469 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24021675 | ||
| Pubmed | Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. | 8.02e-06 | 2 | 99 | 2 | 19282482 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24084593 | ||
| Pubmed | Roles of GSK3β in odor habituation and spontaneous neural activity of the mouse olfactory bulb. | 8.02e-06 | 2 | 99 | 2 | 23658842 | |
| Pubmed | HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells. | 8.02e-06 | 2 | 99 | 2 | 27181362 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 29263426 | ||
| Pubmed | NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling. | 8.02e-06 | 2 | 99 | 2 | 36978001 | |
| Pubmed | Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer. | 8.02e-06 | 2 | 99 | 2 | 19424621 | |
| Pubmed | 1.07e-05 | 486 | 99 | 9 | 20936779 | ||
| Pubmed | High-throughput RNAi screening reveals novel regulators of telomerase. | 1.22e-05 | 16 | 99 | 3 | 21531765 | |
| Pubmed | Comprehensive interactome of Otx2 in the adult mouse neural retina. | 1.62e-05 | 53 | 99 | 4 | 26426291 | |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 1.62e-05 | 53 | 99 | 4 | 15572359 | |
| Pubmed | ERCC1 IFT172 ACO1 CORO1C SETDB1 ABLIM1 THOP1 DST STXBP1 PTPRK MACF1 TNKS TNKS2 DNMT1 | 1.67e-05 | 1285 | 99 | 14 | 35914814 | |
| Pubmed | 1.77e-05 | 653 | 99 | 10 | 22586326 | ||
| Pubmed | 1.77e-05 | 18 | 99 | 3 | 24025402 | ||
| Pubmed | CORO1C PAK5 NSD1 GSK3B ABLIM1 DST ANAPC1 GIGYF2 MACF1 TNKS MAPK3 DNMT1 | 1.92e-05 | 963 | 99 | 12 | 28671696 | |
| Pubmed | HIF1A ESRRB GATA1 ABLIM1 HLTF ZNF638 ABLIM2 UHRF2 PLXNA2 DNMT1 NPAS2 | 1.96e-05 | 808 | 99 | 11 | 20412781 | |
| Pubmed | 2.00e-05 | 401 | 99 | 8 | 25852190 | ||
| Pubmed | Mitotic WNT signalling orchestrates neurogenesis in the developing neocortex. | 2.10e-05 | 19 | 99 | 3 | 34431536 | |
| Pubmed | 2.22e-05 | 407 | 99 | 8 | 12693553 | ||
| Pubmed | Epigenetic alterations regulate estradiol-induced enhancement of memory consolidation. | 2.40e-05 | 3 | 99 | 2 | 20212170 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 32442396 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 17273789 | ||
| Pubmed | Regulation of the HIF-1alpha stability by histone deacetylases. | 2.40e-05 | 3 | 99 | 2 | 17273746 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 17369852 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 2.40e-05 | 3 | 99 | 2 | 12399109 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 28102109 | ||
| Pubmed | The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer. | 2.40e-05 | 3 | 99 | 2 | 32525044 | |
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 2.40e-05 | 3 | 99 | 2 | 12270931 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 28069743 | ||
| Pubmed | Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase. | 2.40e-05 | 3 | 99 | 2 | 25637186 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 26951539 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 15155736 | ||
| Pubmed | LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome. | 2.40e-05 | 3 | 99 | 2 | 33932340 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 21151116 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 23548937 | ||
| Pubmed | Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma. | 2.40e-05 | 3 | 99 | 2 | 30914315 | |
| Pubmed | A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma. | 2.40e-05 | 3 | 99 | 2 | 29136244 | |
| Pubmed | The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. | 2.40e-05 | 3 | 99 | 2 | 19098913 | |
| Pubmed | MicroRNA-363 and GATA-1 are regulated by HIF-1α in K562 cells under hypoxia. | 2.40e-05 | 3 | 99 | 2 | 27485543 | |
| Pubmed | Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. | 2.40e-05 | 3 | 99 | 2 | 11739745 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 18263590 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25939383 | ||
| Interaction | APC interactions | EPB41L4A GSK3B KIFAP3 SETDB1 DST GIGYF2 MACF1 TNKS PRNP RBFOX2 HDAC1 DNMT1 | 4.61e-07 | 389 | 99 | 12 | int:APC |
| Interaction | SP1 interactions | HIF1A ESRRB GATA1 GSK3B DDX5 FASN HLTF MAPK3 DNAJC3 HDAC1 DNMT1 | 1.80e-06 | 365 | 99 | 11 | int:SP1 |
| Interaction | CAMSAP2 interactions | 1.85e-06 | 169 | 99 | 8 | int:CAMSAP2 | |
| Interaction | ZFPM1 interactions | 3.74e-06 | 22 | 99 | 4 | int:ZFPM1 | |
| Interaction | ESRRA interactions | 1.96e-05 | 67 | 99 | 5 | int:ESRRA | |
| Interaction | HDAC1 interactions | HIF1A ESRRB GATA1 DENND4C DDX5 SETDB1 FASN DST CHD5 ZNF638 GIGYF2 ASCC3 UHRF2 ZMYM3 HDAC1 DNMT1 BAHCC1 | 2.60e-05 | 1108 | 99 | 17 | int:HDAC1 |
| Interaction | RCOR1 interactions | ESRRB DENND4C FASN DST ANAPC1 GIGYF2 ASCC3 UHRF2 ZMYM3 PRNP HDAC1 | 3.10e-05 | 494 | 99 | 11 | int:RCOR1 |
| Interaction | IQGAP1 interactions | HIF1A CORO1C PAK5 GSK3B DDX5 ABLIM1 DST LRP6 MAPK3 ASCC3 PRNP HDAC1 | 3.27e-05 | 591 | 99 | 12 | int:IQGAP1 |
| Interaction | USP7 interactions | HIF1A PAK5 GATA1 NSD1 EPB41L4A SPIN4 GSK3B DDX5 FAT2 DST HLTF ZNF638 GIGYF2 MACF1 UHRF2 PRNP HDAC1 DNMT1 | 6.42e-05 | 1313 | 99 | 18 | int:USP7 |
| Interaction | SYNE3 interactions | 6.60e-05 | 444 | 99 | 10 | int:SYNE3 | |
| Interaction | HDAC4 interactions | HIF1A IFT172 GATA1 DENND4C GSK3B DDX5 THOP1 ZNF638 GIGYF2 TNKS MAPK3 DNAJC3 DNMT1 | 7.07e-05 | 744 | 99 | 13 | int:HDAC4 |
| GeneFamily | Arachidonate lipoxygenases | 2.26e-04 | 6 | 71 | 2 | 407 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.18e-04 | 34 | 71 | 3 | 487 | |
| GeneFamily | Tudor domain containing | 4.10e-04 | 37 | 71 | 3 | 780 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.19e-04 | 8 | 71 | 2 | 939 | |
| GeneFamily | PHD finger proteins | 4.32e-04 | 90 | 71 | 4 | 88 | |
| GeneFamily | PHD finger proteins|NuRD complex | 9.78e-04 | 12 | 71 | 2 | 1305 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.99e-03 | 17 | 71 | 2 | 684 | |
| GeneFamily | PWWP domain containing | 3.34e-03 | 22 | 71 | 2 | 1147 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 3.97e-03 | 24 | 71 | 2 | 615 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.30e-03 | 25 | 71 | 2 | 504 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIF1A GSK3B KIFAP3 SETDB1 DST PTPRK HLTF ZNF638 GIGYF2 MACF1 TNKS ASCC3 RAB21 PLOD2 RBFOX2 | 6.65e-07 | 856 | 98 | 15 | M4500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | ARHGAP42 TGFBR1 USP31 SETDB1 ANGPTL2 ANAPC1 GIGYF2 TNKS TNKS2 PLXNA2 RBFOX2 | 2.08e-07 | 312 | 98 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 4.49e-07 | 149 | 98 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TGFBR1 USP31 ANGPTL2 PTPRK ANAPC1 TNKS ASCC3 TNKS2 DNAJC3 PLXNA2 RBFOX2 | 1.65e-06 | 385 | 98 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | HIF1A NSD1 GSK3B TGFBR1 USP31 SETDB1 ANGPTL2 ANAPC1 ASCC3 TNKS2 RBFOX2 | 2.22e-06 | 397 | 98 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.37e-06 | 101 | 98 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.15e-05 | 165 | 98 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 1.18e-05 | 231 | 98 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.68e-05 | 69 | 98 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.22e-05 | 330 | 98 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 3.05e-05 | 78 | 98 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 5.25e-05 | 209 | 98 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.25e-05 | 209 | 98 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | 8.09e-05 | 390 | 98 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | NSD1 LANCL1 TGFBR1 USP31 SETDB1 DST GIGYF2 TNKS ASCC3 TNKS2 CRISPLD1 PLXNA2 RBFOX2 | 8.44e-05 | 806 | 98 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ARHGAP42 LANCL1 TGFBR1 USP31 SETDB1 DST ANGPTL2 ANAPC1 GIGYF2 TNKS TNKS2 PLXNA2 RBFOX2 | 8.44e-05 | 806 | 98 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_200 | 8.61e-05 | 156 | 98 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 1.10e-04 | 163 | 98 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.12e-04 | 407 | 98 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_200 | 1.82e-04 | 61 | 98 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | ARHGAP42 LARGE2 TGFBR1 TENM1 HLTF SCUBE3 GIGYF2 ROS1 ASCC3 TNKS2 DNAJC3 RBFOX2 | 2.32e-04 | 774 | 98 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_500 | 2.56e-04 | 122 | 98 | 5 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.82e-04 | 194 | 98 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | ARHGAP42 NSD1 TGFBR1 DST HLTF SCUBE3 GIGYF2 TNKS ASCC3 TNKS2 DNAJC3 RBFOX2 | 2.96e-04 | 795 | 98 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.11e-04 | 369 | 98 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 3.41e-04 | 201 | 98 | 6 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | HIF1A NSD1 GSK3B TGFBR1 USP31 SETDB1 ANGPTL2 ANAPC1 GIGYF2 ASCC3 TNKS2 RBFOX2 | 3.55e-04 | 811 | 98 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.60e-04 | 203 | 98 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 4.03e-04 | 75 | 98 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 5.14e-04 | 34 | 98 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.83e-04 | 146 | 98 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 6.05e-04 | 408 | 98 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.20e-04 | 84 | 98 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_500 | 6.66e-04 | 414 | 98 | 8 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 7.42e-04 | 421 | 98 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 7.71e-04 | 89 | 98 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.04e-04 | 90 | 98 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 8.14e-04 | 427 | 98 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_200 | 8.32e-04 | 40 | 98 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | GSK3B TGFBR1 USP31 DST TENM1 HLTF GIGYF2 TNKS TNKS2 CRISPLD1 RBFOX2 | 8.36e-04 | 769 | 98 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 8.93e-04 | 541 | 98 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | IFT172 LANCL1 TGFBR1 USP31 HLTF SCUBE3 TNKS TNKS2 UHRF2 CRISPLD1 RBFOX2 | 9.28e-04 | 779 | 98 | 11 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.60e-08 | 200 | 99 | 8 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-07 | 192 | 99 | 7 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-07 | 195 | 99 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.04e-07 | 198 | 99 | 7 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-07 | 199 | 99 | 7 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.25e-07 | 200 | 99 | 7 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.25e-07 | 200 | 99 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.25e-07 | 200 | 99 | 7 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 9.58e-07 | 147 | 99 | 6 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 4.64e-06 | 193 | 99 | 6 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.78e-06 | 194 | 99 | 6 | 54fda501ce1d041285d04c3c96c15983f454bed4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-06 | 194 | 99 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-06 | 194 | 99 | 6 | 412c2b8eb522da6c84f8b00d32d6f0bee555251f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.07e-06 | 196 | 99 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.07e-06 | 196 | 99 | 6 | eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.07e-06 | 196 | 99 | 6 | 2793ad692d49b3ee78a5cd2d8e0220bf5188a686 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.07e-06 | 196 | 99 | 6 | aae79eafe5bc2c7de16958994a2fe97439d7bea1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 197 | 99 | 6 | 4f022bae7af2ca23689cc0d35046a7e23dba6e9c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.22e-06 | 197 | 99 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 197 | 99 | 6 | 69671ed173057a67265ac39ed03fbd57dbd22c5c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 198 | 99 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 198 | 99 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 198 | 99 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-06 | 198 | 99 | 6 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 198 | 99 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-06 | 198 | 99 | 6 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 198 | 99 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-Neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.53e-06 | 199 | 99 | 6 | 0c5a5fbb174a013be10961f0db65c65c797ab4af | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 5.53e-06 | 199 | 99 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.53e-06 | 199 | 99 | 6 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 5.53e-06 | 199 | 99 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.53e-06 | 199 | 99 | 6 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 200 | 99 | 6 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 200 | 99 | 6 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 200 | 99 | 6 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-05 | 157 | 99 | 5 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 169 | 99 | 5 | d3e6c75e5eda133fb6535cfe6c6a1026641f26ac | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.01e-05 | 171 | 99 | 5 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-05 | 172 | 99 | 5 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-05 | 173 | 99 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.35e-05 | 174 | 99 | 5 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 176 | 99 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-05 | 176 | 99 | 5 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.72e-05 | 177 | 99 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 177 | 99 | 5 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.98e-05 | 179 | 99 | 5 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.12e-05 | 180 | 99 | 5 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.12e-05 | 180 | 99 | 5 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 5.12e-05 | 180 | 99 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.12e-05 | 180 | 99 | 5 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.39e-05 | 182 | 99 | 5 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 182 | 99 | 5 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.39e-05 | 182 | 99 | 5 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 182 | 99 | 5 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 182 | 99 | 5 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.39e-05 | 182 | 99 | 5 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 5.53e-05 | 183 | 99 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-05 | 184 | 99 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.68e-05 | 184 | 99 | 5 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 5.68e-05 | 184 | 99 | 5 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 5.82e-05 | 185 | 99 | 5 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.98e-05 | 186 | 99 | 5 | 4a5264e32ba004ed58dc4102d84e4bc4dbbe1440 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.98e-05 | 186 | 99 | 5 | 528ee88f6e27863c7bcdffd4416cbbd83fc65e9d | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.13e-05 | 187 | 99 | 5 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class (2021.01.30) | 6.13e-05 | 187 | 99 | 5 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.13e-05 | 187 | 99 | 5 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.13e-05 | 187 | 99 | 5 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.13e-05 | 187 | 99 | 5 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.29e-05 | 188 | 99 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.29e-05 | 188 | 99 | 5 | 013162466a3334b6967c0cb670c8577d809b1396 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.29e-05 | 188 | 99 | 5 | be25371e6459504b5f0c9ece3a0fe8f80c7824ca | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.44e-05 | 189 | 99 | 5 | 8419d62e6991851bdc6ad861f5c9086ff808b222 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 6.44e-05 | 189 | 99 | 5 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.44e-05 | 189 | 99 | 5 | e97c64609b1f8158d750edb869df56e5bd10538b | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 6.44e-05 | 189 | 99 | 5 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 190 | 99 | 5 | 0eef5a8bd88ef8a25a67d9dd522d9472fa4b3d2f | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 6.61e-05 | 190 | 99 | 5 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-05 | 190 | 99 | 5 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 190 | 99 | 5 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 190 | 99 | 5 | 2724e8f375d8d9f5f2a77444e0491af264babac5 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 6.61e-05 | 190 | 99 | 5 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 6.61e-05 | 190 | 99 | 5 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 6.61e-05 | 190 | 99 | 5 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 190 | 99 | 5 | 6514f00d222eef08c282face7f177259bca62f0e | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 190 | 99 | 5 | 11fbd4e9f02750354b3aadf30edc991f8d4f8f41 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 190 | 99 | 5 | 148d43dd72e2e22b2cd68e17fedae6bd98b32aee | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM1|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.77e-05 | 191 | 99 | 5 | bd641aab36276dd952a7265ee79ba455b38d8e6b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 191 | 99 | 5 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.77e-05 | 191 | 99 | 5 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.77e-05 | 191 | 99 | 5 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.77e-05 | 191 | 99 | 5 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.77e-05 | 191 | 99 | 5 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.77e-05 | 191 | 99 | 5 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.77e-05 | 191 | 99 | 5 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related-OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.94e-05 | 192 | 99 | 5 | 5d9bc234f01c73b2531edf8960588d5b6cf260a7 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 192 | 99 | 5 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-05 | 192 | 99 | 5 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 6.94e-05 | 192 | 99 | 5 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-05 | 192 | 99 | 5 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.12e-06 | 194 | 99 | 8 | 2433_DN | |
| Disease | Prostatic Neoplasms | HIF1A GSK3B SETDB1 PTPRK MAPK3 DNAJC3 ALOX5 ALOX12B ZMYM3 PRNP DNMT1 | 5.89e-06 | 616 | 97 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | HIF1A GSK3B SETDB1 PTPRK MAPK3 DNAJC3 ALOX5 ALOX12B ZMYM3 PRNP DNMT1 | 5.89e-06 | 616 | 97 | 11 | C0376358 |
| Disease | Mainzer-Saldino Disease | 1.07e-05 | 2 | 97 | 2 | C1849437 | |
| Disease | Congenital anosmia | 1.07e-05 | 2 | 97 | 2 | C0393778 | |
| Disease | schizophrenia (is_marker_for) | 1.35e-05 | 44 | 97 | 4 | DOID:5419 (is_marker_for) | |
| Disease | Adenocarcinoma of lung (disorder) | 6.27e-05 | 206 | 97 | 6 | C0152013 | |
| Disease | lung carcinoma (implicated_via_orthology) | 1.06e-04 | 5 | 97 | 2 | DOID:3905 (implicated_via_orthology) | |
| Disease | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 1.59e-04 | 6 | 97 | 2 | C1866282 | |
| Disease | myelofibrosis (is_marker_for) | 1.59e-04 | 6 | 97 | 2 | DOID:4971 (is_marker_for) | |
| Disease | melanoma | 1.73e-04 | 248 | 97 | 6 | C0025202 | |
| Disease | colorectal cancer (is_marker_for) | 1.74e-04 | 157 | 97 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Mood Disorders | 2.38e-04 | 168 | 97 | 5 | C0525045 | |
| Disease | Neoplasm Invasiveness | 3.62e-04 | 184 | 97 | 5 | C0027626 | |
| Disease | Creutzfeldt Jacob Disease | 3.79e-04 | 9 | 97 | 2 | EFO_0004226 | |
| Disease | Hereditary Diffuse Gastric Cancer | 4.22e-04 | 293 | 97 | 6 | C1708349 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 4.42e-04 | 45 | 97 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | Stomach Neoplasms | 4.54e-04 | 297 | 97 | 6 | C0038356 | |
| Disease | alopecia areata (is_marker_for) | 4.73e-04 | 10 | 97 | 2 | DOID:986 (is_marker_for) | |
| Disease | Malignant neoplasm of stomach | 4.78e-04 | 300 | 97 | 6 | C0024623 | |
| Disease | acute myeloid leukemia (is_marker_for) | 5.69e-04 | 49 | 97 | 3 | DOID:9119 (is_marker_for) | |
| Disease | Jeune thoracic dystrophy | 5.77e-04 | 11 | 97 | 2 | C0265275 | |
| Disease | Schizophrenia | GABRG2 CACNA1F GSK3B SETDB1 STXBP1 MAPK3 PLXNA2 HDAC1 DNMT1 NPAS2 | 6.58e-04 | 883 | 97 | 10 | C0036341 |
| Disease | salicylurate measurement | 8.15e-04 | 13 | 97 | 2 | EFO_0010532 | |
| Disease | Short Rib-Polydactyly Syndrome | 8.15e-04 | 13 | 97 | 2 | C0036996 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 8.15e-04 | 13 | 97 | 2 | C0751122 | |
| Disease | Saldino-Noonan Syndrome | 9.49e-04 | 14 | 97 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 9.49e-04 | 14 | 97 | 2 | C0024507 | |
| Disease | Testicular Germ Cell Tumor | 9.49e-04 | 14 | 97 | 2 | C1336708 | |
| Disease | ovarian neoplasm | 1.02e-03 | 134 | 97 | 4 | C0919267 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.09e-03 | 15 | 97 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of ovary | 1.10e-03 | 137 | 97 | 4 | C1140680 | |
| Disease | respiratory system disease | 1.36e-03 | 145 | 97 | 4 | EFO_0000684 | |
| Disease | Dementia | 1.41e-03 | 17 | 97 | 2 | C0497327 | |
| Disease | Benign Neoplasm | 1.48e-03 | 68 | 97 | 3 | C0086692 | |
| Disease | Neoplasms | 1.48e-03 | 68 | 97 | 3 | C0027651 | |
| Disease | Pancreatic carcinoma | 1.76e-03 | 19 | 97 | 2 | C0235974 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.78e-03 | 156 | 97 | 4 | C0007131 | |
| Disease | alkaline phosphatase measurement | PGAP4 GSK3B ABCA6 CLPTM1 SCUBE3 MACF1 TNKS TNKS2 FAM118B DNMT1 | 1.87e-03 | 1015 | 97 | 10 | EFO_0004533 |
| Disease | cancer (implicated_via_orthology) | 1.94e-03 | 268 | 97 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | corneal hysteresis | 1.96e-03 | 20 | 97 | 2 | EFO_0010066 | |
| Disease | age of onset of asthma | 2.27e-03 | 79 | 97 | 3 | OBA_2001001 | |
| Disease | FEV/FEC ratio | ARHGAP42 SOX30 NSD1 DENND3 DDX5 FCGBP DST ANAPC1 SCUBE3 MAPK3 D2HGDH | 2.34e-03 | 1228 | 97 | 11 | EFO_0004713 |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.36e-03 | 80 | 97 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Hodgkins lymphoma | 2.53e-03 | 82 | 97 | 3 | EFO_0000183 | |
| Disease | QRS duration, response to sulfonylurea | 2.59e-03 | 23 | 97 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | Malignant neoplasm of breast | HIF1A PFKFB4 APOBEC3A FASN P3H2 CHD5 TENM1 MACF1 CNGA2 DNMT1 | 2.81e-03 | 1074 | 97 | 10 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARVVFDQDGYYYPDS | 186 | P21399 | |
| RKYDFLIIEDDPYYF | 221 | Q8N5Z0 | |
| DRQDLYYLAGTYDPT | 2611 | Q9P281 | |
| PRDSYSGDALYDLYA | 546 | Q8N7J2 | |
| RGYEAFLEALEFYYP | 91 | Q9BWT7 | |
| LEDFLEYEGYKYERI | 1056 | Q8TDI0 | |
| EDLYPEHYRKYSDYI | 966 | P26358 | |
| YDIERPDLITYEPFY | 396 | O14639 | |
| YEPFYTSGYDDKQER | 406 | O14639 | |
| AARIYDYDPLYKEAL | 126 | P31941 | |
| YFDKILPYGDERHYS | 416 | Q8N139 | |
| YRGYQYLLEPGDFRH | 201 | P53674 | |
| RYFEITDESPYVHYL | 291 | Q9ULV4 | |
| AYYRYIEKPPEDLDA | 136 | Q9ULD4 | |
| YISKDGLPYCEADYH | 191 | Q6H8Q1 | |
| YASFRLEPESEYYKL | 381 | Q9UKU9 | |
| YGVVAQYYRPLHDEY | 76 | A2RUS2 | |
| GDPDNYIAYYRRATV | 66 | Q13217 | |
| PIYYRDSNGAILVYD | 86 | Q9UL25 | |
| YRQYYVEAFGDPSER | 361 | Q96L73 | |
| DGYGRVYTADPYHAL | 351 | O43251 | |
| DIDFLPAYSLYDYLR | 521 | Q8N3Y3 | |
| PFEVLGTSGYDYYHI | 276 | Q99743 | |
| DLKLGPYVDHYYRDY | 796 | Q9H1A4 | |
| YREKSLYGDDLDPYY | 146 | Q9P286 | |
| LYGDDLDPYYRGSHA | 151 | Q9P286 | |
| IDAYAEDHGPIYNYR | 1096 | O60840 | |
| LYLHLYDVFGDPAYL | 71 | O43813 | |
| PRFVVYSYKYVHDDG | 66 | O60234 | |
| YYAVNYPLRDGIDDE | 221 | Q13547 | |
| GYIDYYEFVAALHPN | 7251 | Q03001 | |
| EPEELLGRSIYEYYH | 266 | Q16665 | |
| DLPDELLYGRAGYLY | 191 | Q9NS86 | |
| YDYPNSSEDYIHRIG | 416 | P17844 | |
| SPEEAGRYLETYKAY | 201 | P07992 | |
| DYVDPDIFYAGIRIF | 236 | Q6ZQW0 | |
| DLDRSGIPYLDYRTY | 1306 | O75051 | |
| EDYTYFRIDPYLGDI | 2111 | Q9NYQ8 | |
| YRYRYPKGESYEDLV | 356 | Q16877 | |
| YHRDAGLPVYLYEFE | 436 | Q5XG92 | |
| DGYIDYYEFVAALHP | 3221 | O94854 | |
| HAIAIDYDPVEGYIY | 361 | O75581 | |
| VEEALAHPYLEQYYD | 321 | P27361 | |
| YVPVANRYEGTEDDY | 161 | Q9BRR3 | |
| CEGPQRFEEYEYLGY | 251 | Q8IVL5 | |
| YAAPELFRDEHYIGI | 236 | Q8IY84 | |
| YAALEDYHPAELYRA | 56 | Q7Z6J2 | |
| ALSPDGYYARSEDYV | 431 | O00469 | |
| PRYEDYVDQHYKEFL | 1386 | Q9UG01 | |
| AYYRDAEAYRHSPVF | 61 | P15976 | |
| SPYEVHDYIRAYLGD | 1166 | Q6Y7W6 | |
| YYVAVGEDEFKDLPY | 196 | A2VCK2 | |
| ETDFGLRVAYDLVYY | 3761 | Q9Y6R7 | |
| YKEGSDRYYPPREEE | 241 | Q9H336 | |
| LEFSSYGYPREEIVY | 206 | P18507 | |
| YYRAPELIFGATDYT | 221 | P49841 | |
| AYKAGLIFRYPEEDY | 206 | Q5VZ89 | |
| QDLPGYYYRDDSLAV | 491 | O75342 | |
| ISYGDDYADLPEYFK | 301 | Q9BPY3 | |
| DVHLNFYVYYGPDRI | 501 | Q14527 | |
| RSLPYDDKLVYAEDY | 291 | O95718 | |
| YKELRLRGYDYGPHF | 991 | P49327 | |
| ELGDYDPYKHTAGYV | 146 | Q9HCS5 | |
| ARGFQVPYVTYDEDY | 911 | Q9NQ36 | |
| ARGFQIPYVTYDEDY | 906 | Q8IX30 | |
| PYYYFTRKPEEADRE | 726 | Q96RY7 | |
| VKRLPLEYSYGEYRD | 321 | P07358 | |
| DGYVYKYDLSLPVER | 396 | Q8N465 | |
| EQYLYGDDRIEPYIH | 696 | Q92845 | |
| ADYYIIAGVIYQAPD | 96 | O75586 | |
| APEQYRFCYDVALEY | 1421 | Q15262 | |
| EGVCDKSPLERYYDY | 196 | P08582 | |
| ESKEDIPYYFYRDDG | 461 | P09917 | |
| YHEGYELAQEFAPYK | 211 | A6NI28 | |
| PGEHAKDEYVLYYYS | 61 | Q86YT9 | |
| PYEISRAPDELHYTY | 386 | P04843 | |
| YVYPDERTALYGKFI | 146 | Q8WTS6 | |
| EILYTPYGDIYHDTY | 2336 | Q9UKZ4 | |
| AYSAYNPEVGYHRDL | 176 | Q86UD7 | |
| ATLKEYPAVRYRGEY | 181 | P61764 | |
| PECLSYYEDRYPKHE | 646 | O94993 | |
| YYEDRYPKHEGIFST | 651 | O94993 | |
| FYYILDITYGKEDVP | 676 | Q15047 | |
| SIGGIHEDYQLPYYD | 416 | P36897 | |
| EYYDGKTRRYVDFPI | 1666 | Q8N3C0 | |
| VKFDAVSGDYYPIIY | 266 | O96005 | |
| SEEGPADEYYIIYRN | 41 | Q8NHS4 | |
| NITDPEYGYLAREYI | 311 | Q16280 | |
| QRKRDGPDLAEYYYD | 81 | C9JXX5 | |
| DVIYHIQYDEYPESG | 206 | Q96PU4 | |
| YAPEEGNRYDGIYKV | 576 | Q96PU4 | |
| YKDGDLRIIPDSNYY | 171 | Q56A73 | |
| EYVIYRGEQAYPEYL | 1291 | O95271 | |
| YEGGYYHGKLIFPRE | 56 | Q8N2K1 | |
| RPIIHFGSDYEDRYY | 136 | P04156 | |
| HVAPDGRIYYYNADD | 101 | Q6NWY9 | |
| GYVFYLLRDGIYRAD | 421 | P08922 | |
| LAEYVIYRGEQAYPE | 1136 | Q9H2K2 | |
| AGSAPRYLLYYRSEE | 61 | Q9UKI3 | |
| YGLGRDPEDYIYDLY | 696 | Q70CQ4 | |
| FYLDLYPREGKYGHA | 411 | P52888 | |
| KYGYTEDPLEVRIYD | 216 | Q14966 | |
| NGERYEPDSIYYLCL | 1126 | Q14202 | |
| NVADYYPEYKLLFEG | 266 | P61421 |